Researchers Highlight Advances in Cancer Detection

Leading medical researchers, doctors, and innovators convened at the NXT Conclave 2026 in New Delhi to discuss transformative technologies improving cancer care. The panel detailed breakthroughs in AI-based thermal screening for breast cancer, targeted drug delivery via injectable hydrogels, and advanced immunotherapies. Experts emphasized that these innovations aim to overcome barriers of cost and accessibility, significantly boost early detection rates, and improve survival outcomes for patients globally.

Key Takeaways:

AI Thermal Screening: Portable, radiation-free AI system screens for breast cancer at one-tenth the cost of mammograms, already used for nearly 500,000 women.
High Survival with Early Detection: Survival rates can exceed 90% when cancer is detected in its earliest stages, though screening rates remain critically low.
Targeted Drug Delivery: Experimental injectable hydrogel technology localized chemotherapy, reducing tumor size by 75% in 18 days during studies.
Immunotherapy Advances: Research into CAR-T cell therapy and biomaterial implants is training the immune system to better recognize and attack cancer cells.

AI-Powered Screening Aims to Democratize Early Detection

A key discussion focused on overcoming the stark reality that only about 1.3% of women in India undergo mammography. Experts presented an AI-powered thermal imaging technology designed to address four key barriers: affordability, accessibility, accuracy, and acceptability. This portable system uses infrared imaging and machine learning to detect tumors, enabling low-cost screening even in remote regions and aiming to curb the nearly 276 daily breast cancer deaths in India.

Targeted Therapies Minimize Treatment Side Effects

Researchers showcased innovations that deliver treatment directly to tumors, sparing healthy tissue. A scientist from IIT Guwahati described an injectable hydrogel that releases chemotherapy drugs locally, potentially reducing common systemic side effects. Separately, panelists discussed progress in immunotherapy, including the exploration of biomaterial implants to stimulate immune responses against solid tumors, building on the success of CAR-T therapies for blood cancers.

Early Detection Remains Critical for Improving Outcomes

Experts unanimously stressed that timely diagnosis is paramount, citing cancers like pancreatic cancer that often present with late-stage symptoms. Research into predictive tools, such as analyzing exosomes released by cancer cells to forecast therapy resistance, was highlighted as a frontier for personalizing care. The session framed these technological leaps as essential tools for shifting cancer from a often fatal diagnosis to a more manageable condition.